Next Gen Diagnostics Launches NGD Infection Prevention to Provide Real-Time Transmission Detection

Next Gen Diagnostics (NGD) today announced that January 1 the Company will spin off its Infection Prevention division into an independent company, NGD Infection Prevention, focused on the implementation of real-time genomic transmission detection across U.S. hospitals. The move is in response to the broadening recognition that sequencing of infection has become a practical means to detect and prevent transmission in hospitals and control the associated financial and human costs.